Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Simvastatin in Preoperative Breast Cancer
NCT05464810Phase 1Recruiting
- Sponsor
- Emory University
- Start
- Sep 2022
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of simvastatin in breast cancer (2 arms), sponsored by Emory University. Primary endpoint: Mean percentage change in Ki-67 at 14 days. Started Sep 2022; status: recruiting.
02
Drugs
simvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05464810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05464810.